Home Biosimilar Antibodies Apoptosis CD markers Belantamab (Anti-TNFRSF17 / BCMA / CD269) For research use only.
Not for use in humans.

Belantamab (Anti-TNFRSF17 / BCMA / CD269)

Synonyms: GSK2857914

Belantamab (Anti-TNFRSF17 / BCMA / CD269) is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA) that can be used in the synthesis of an antibody-drug conjugate (ADC), Belantamab mafodotin. MW : 145.5 KD.

Belantamab (Anti-TNFRSF17 / BCMA / CD269)

Click to purchase the isotype control of Belantamab (Anti-TNFRSF17 / BCMA / CD269)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Belantamab (Anti-TNFRSF17 / BCMA / CD269) is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA) that can be used in the synthesis of an antibody-drug conjugate (ADC), Belantamab mafodotin. MW : 145.5 KD.

Product Details

CAS No. 2061894-48-0
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Belantamab (Anti-TNFRSF17 / BCMA / CD269) | Belantamab (Anti-TNFRSF17 / BCMA / CD269) supplier | purchase Belantamab (Anti-TNFRSF17 / BCMA / CD269) | Belantamab (Anti-TNFRSF17 / BCMA / CD269) cost | Belantamab (Anti-TNFRSF17 / BCMA / CD269) manufacturer | order Belantamab (Anti-TNFRSF17 / BCMA / CD269) | Belantamab (Anti-TNFRSF17 / BCMA / CD269) distributor